BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10996659)

  • 1. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
    Braat EA; Collen A; Jie AF; Grimbergen JM; Rijken DC
    Biochim Biophys Acta; 2000 Sep; 1497(3):351-8. PubMed ID: 10996659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
    J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin.
    Braat EA; Los P; Rijken DC
    Blood Coagul Fibrinolysis; 1998 Jul; 9(5):419-27. PubMed ID: 9712290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
    Braat EA; Jie AF; Ronday HK; Beekman B; Rijken DC
    Ann Rheum Dis; 2000 Apr; 59(4):315-8. PubMed ID: 10733483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator.
    Schenk-Braat EA; Morser J; Rijken DC
    Eur J Biochem; 2001 Nov; 268(21):5562-9. PubMed ID: 11683879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
    Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.
    de Munk GA; Groeneveld E; Rijken DC
    J Clin Invest; 1991 Nov; 88(5):1680-4. PubMed ID: 1658049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
    Braat EA; Nauland U; Dooijewaard G; Rijken DC
    Thromb Haemost; 1996 Jun; 75(6):908-14. PubMed ID: 8822585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
    Fleury V; Lijnen HR; Anglés-Cano E
    J Biol Chem; 1993 Sep; 268(25):18554-9. PubMed ID: 8103046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects.
    Braat EA; Levi M; Bos R; Haverkate F; Lassen MR; de Maat MP; Rijken DC
    J Lab Clin Med; 1999 Aug; 134(2):161-7. PubMed ID: 10444030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
    Lee SW; Ellis V; Dichek DA
    J Biol Chem; 1994 Jan; 269(4):2411-8. PubMed ID: 8300567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.
    Schwartz BS
    J Biol Chem; 1994 Mar; 269(11):8319-23. PubMed ID: 7907591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin.
    de Munk GA; Parkinson JF; Groeneveld E; Bang NU; Rijken DC
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):655-9. PubMed ID: 8384442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model.
    Molinari A; Giorgetti C; Lansen J; Vaghi F; Orsini G; Faioni EM; Mannucci PM
    Thromb Haemost; 1992 Feb; 67(2):226-32. PubMed ID: 1320301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).
    Nauland U; Rijken DC
    Eur J Biochem; 1994 Jul; 223(2):497-501. PubMed ID: 8055919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
    Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15139-45. PubMed ID: 3170576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator.
    Lenich C; Liu JN; Gurewich V
    Blood; 1997 Nov; 90(9):3579-86. PubMed ID: 9345041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.